Our firm regularly assists corporate healthcare clients with a variety of transactional matters, including mergers and acquisitions, corporate financing and structuring, private equity, and the organization and operation of new and existing ventures.
Our lawyers leverage decades of operational and strategic experience in the healthcare and life sciences industries to assist clients in a range of corporate transactional matters regarding due diligence, licensure, mergers and acquisitions, financing, and a host of other issues.
We regularly assist clients in the structuring and negotiation of complex transactional matters involving large healthcare entities. With a keen understanding of the ever-evolving healthcare industry, our lawyers prioritize the mitigation of future risk to clients’ businesses and financial stability, ensuring that these transactions meet robust state and federal regulatory compliance requirements.
Our business foresight and vision, combined with strong foundational corporate and finance experience, and an ability to navigate the healthcare regulatory world make Leech Tishman Nelson Hardiman a standout choice for handling clients’ healthcare and life sciences transactions.
We have a wealth of experience in healthcare and life sciences transactional matters, including physician practice management, telehealth, behavioral health, and post-acute and senior care, among other areas. We are frequently asked to handle both the corporate and regulatory aspects of “middle market” deals and transactions involving not-for-profit entities. Start-up and early-stage clients often turn to us from inception to guide their corporate structuring, as well as to negotiate acquisitions or other liquidity events.
Our firm possesses particular expertise in managing healthcare and life science-specific risks, including licensing and changes of ownership (CHOW) issues, fraud and abuse issues related to marketing and potential kickbacks, and data privacy and cybersecurity concerns. In addition, many clients turn to us to address critical issues that could delay or prevent transactions from moving forward, including healthcare licensing, operation, and reimbursement.
Services
